JAKARTA, U.S. Embassy & Consulates in Indonesia -- The United States Government today announced $30 million in urgent COVID-19 assistance for Indonesia to purchase additional oxygen, collaborate on ways to boost local oxygen production, and provide medicines to treat COVID-19 patients and save lives. This assistance, administered through the U.S. Agency for International Development (USAID), will also enhance the rollout of vaccines by supporting a robust cold chain for distribution, support vaccination facilities readiness, and help disseminate health information to educate citizens to reduce vaccine hesitancy.

“We remain committed to our partnership with the government and people of Indonesia at this critical time. Our assistance will help ensure that more people are vaccinated and protected from this deadly disease and strengthen health facilities, enabling them to continue providing critical care and services to COVID-19 patients,” said U.S. Ambassador Sung Y. Kim of the United States Mission to Indonesia. “This support builds on our previous assistance to provide vaccines, improve testing and tracing, enhance treatment, and provide accurate and timely information about the pandemic to keep everyone safe.”

This additional support from the American Rescue Plan Act brings the total U.S. COVID-19 assistance to Indonesia to over $77 million in funding, equipment, and technical support since the start of the pandemic. The U.S. Government, through USAID and other U.S. government agencies, has partnered with Indonesian health experts to improve laboratories, disease surveillance, and rapid-response capacity. In addition, the United States has helped accelerate case detection and tracking and ensure that more people know what to do to protect themselves and each other.

The United States has also donated 1,000 American-made ventilators currently in use in 600 hospitals to help more patients survive and recover. In partnership with the Government of Indonesia and UNICEF through the COVAX Advance Market Commitment (COVAX AMC), a global initiative to support equitable access to COVID-19 vaccines, the United States has delivered a total of eight million safe and effective Moderna vaccine doses to the Indonesian people. The United States has committed an historic $4 billion contribution from the American people through Gavi, the Vaccine Alliance, for the COVAX AMC. Indonesia has received over 19 million vaccine doses through the COVAX AMC.

Over the past 20 years, USAID has invested over $1 billion into Indonesia’s health sector, building a strong foundation for a more effective COVID-19 response. For the past 60 years, USAID has worked in countries around the globe to save millions of lives from diseases such as Ebola, HIV/AIDS, tuberculosis, malaria, and now, COVID-19.

Diseases know no border and the United States remains committed to supporting Indonesia’s COVID-19 response efforts and working with the Government of Indonesia and its people toward the safe reopening of the Indonesian economy.

For more information, visit https://www.usaid.gov/indonesia or contact USAID Communications Specialist at +62 (21) 5083-1000 or sandina@usaid.gov.